Latest Isofol Medical News & Updates

See the latest news and media coverage for Isofol Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Isofol Medical

Biotechnology company developing folate-based cancer drugs

isofolmedical.com
Headquarters
Gothenburg, Sweden
Founded year
2008
Company type
Public company
Number of employees
2–15

Last updated

Latest news about Isofol Medical

In short: Isofol Medical advanced its clinical program for arfolitixorin and successfully secured 18.9 million SEK through a warrant exercise.

Company announcements

  • Isofol Medical

    Isofol Medical calls for annual general meeting on May 19, 2026

    The meeting is held in Gothenburg with proposals on board election, fees, incentive program and emissions. Information is given to shareholders about registration and agenda.

  • Isofol Medical

    Isofol optimizes phase Ib/II study after BfArM approval

    BfArM approves broader inclusion criteria, direct comparison with leucovorin and addition of study centers for faster recruitment.

  • Isofol Medical

    Isofol Medical publishes annual report and corporate governance report for 2025

    The documents are available on the company's website. CEO Petter Segelman Lindqvist comments on progress in clinical development, regulatory dialogues, partnerships and financial position.

  • Isofol Medical

    Isofol receives 18.9 MSEK from TO1 warrant exercise

    The exercise rate was 93.57%. The board decides on a directed new issue to Solasia Pharma K.K. for guarantee commitment. The number of shares increases to 320 491 623.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Isofol Medical

Track Isofol Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Isofol Medical competitors & trending companies

Browse news for competitors to Isofol Medical and other trending companies.